Clinical trialNCT05763121TerminatedPhase 3Interventional

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

SponsorAreteia TherapeuticsEnrollment1,061AsthmaAsthma; EosinophilicEosinophilic Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Salman Siddiqui, MD
Imperial College Healthcare NHS Trust (via Imperial Consultants)
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

401 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site -20054-021
Buenos Aires, Argentina
Research Site 20054-008
Buenos Aires, Argentina
Research Site 20054-011
Buenos Aires, Argentina
Research Site 20054-015
Buenos Aires, Argentina
Research Site 20054-017
Buenos Aires, Argentina
Research Site 20054-022
Buenos Aires, Argentina
Research Site 20054-023
Buenos Aires, Argentina
Research Site 20054-024
Buenos Aires, Argentina
Research Site 20054-054
Buenos Aires, Argentina
Research Site 20054-005
Córdoba, Argentina
Research Site 20054-010
Mendoza, Argentina
Research Site 20054-016
Mendoza, Argentina
Research Site 20054-019
Mendoza, Argentina
Research Site 20054-013
Rosario, Argentina
Research Site 20054-002
San Miguel de Tucumán, Argentina
Research Site 20054-020
San Miguel de Tucumán, Argentina

Brazil

Research Site 20055-004
Porto Alegre, Rio Grande do Sul, Brazil
Research Site 20055-012
Porto Alegre, Rio Grande do Sul, Brazil
Research Site 20055-014
Ribeirão Preto, São Paulo, Brazil
Research Site 20055-009
Santos, São Paulo, Brazil
Research Site 20055-002
Sorocaba, São Paulo, Brazil
Research Site 20055-001
São Bernardo do Campo, São Paulo, Brazil
Research Site 20055-007
Blumenau, Brazil
Research Site 20055-011
Campo Largo, Brazil
Research Site 20055-010
Porto Alegre, Brazil
Research Site 20055-005
Santo André, Brazil
Research Site 20055-003
São Paulo, Brazil
Research Site 20055-008
São Paulo, Brazil

Bulgaria

Research Site 20359-017
Dimitrovgrad, Bulgaria
Research Site 20359-022
Kozloduy, Bulgaria
Research Site 20359-027
Lovech, Bulgaria
Research Site 20359-008
Montana, Bulgaria
Research Site 20359-029
Montana, Bulgaria
Research Site 20359-010
Pernik, Bulgaria
Research Site 20359-023
Pleven, Bulgaria
Research Site 20359-024
Plovdiv, Bulgaria
Research Site 20359-026
Plovdiv, Bulgaria
Research Site 20359-005
Rousse, Bulgaria
Research Site 20359-009
Sliven, Bulgaria
Research Site 20359-033
Sliven, Bulgaria

361 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Jan 2023
Primary completion: 8 Dec 2025
Completion: 8 Dec 2025
Last update posted: 15 Dec 2025
Registered enrollment: 1,061
Registry id: NCT05763121

Cross-registrations

EU-CTR / CTIS (EudraCT)2022-003004-33

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.